AnalyzeDirect Brooks DJ, Ibanez V, Sawle GV, Playford ED, Quinn N, Mathias CJ, Lees AJ, Marsden CD, Bannister R, Frackowiak RSJ. Striatal D2 receptor status in patients with Parkinson’s disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography. Ann Neurol. February 1992;31(2):184-192.
Publication Date
February 1992
How Analyze was Used
“Data Analysis Region of interest (ROI) analysis was performed on SUN 31 60 workstations using image-analysis software (ANALYZE 3.0).”
Keywords
Adult
Aged
Caudate Nucleus/metabolism/radionuclide imaging
Corpus Striatum/metabolism/radionuclide imaging
Humans
Levodopa/pharmacology/therapeutic use
Middle Aged
Nerve Degeneration
Parkinson Disease/drug therapy/metabolism/radionuclide imaging
Putamen/metabolism/radionuclide imaging
Raclopride
Receptors, Dopamine/analysis/drug effects
Salicylamides/diagnostic use/pharmacokinetics
Substantia Nigra/metabolism/radionuclide imaging
Supranuclear Palsy, Progressive/metabolism/radionuclide imaging
Tomography, Emission-Computed
Author Affiliation(s)
MRC Cyclotron Unit, Hammersmith Hospital, London, UK. (DJB, VI, GVS, EDP, RSJF)
Institute of Neurology, London, UK. (DJB, NQ, CJM, AJL, CDM, RB, RSJF)
ID# 3121
Tags: Adult, Aged, Caudate Nucleus/metabolism/radionuclide imaging, Corpus Striatum/metabolism/radionuclide imaging, Dopamine Receptors/analysis/drug effects, Emission-Computed Tomography, Humans, Levodopa/pharmacology/therapeutic use, Middle Aged, Nerve Degeneration, Parkinson Disease/drug therapy/metabolism/radionuclide imaging, Progressive Supranuclear Palsy/metabolism/radionuclide imaging, Putamen/metabolism/radionuclide imaging, Raclopride, Salicylamides/diagnostic use/pharmacokinetics, Substantia Nigra/metabolism/radionuclide imaging